Cover Image
: Afshan Syeda; Kim Yu Gang; Mattsson Jesse; Åkerfelt Malin; Härkönen Pirkko; Baumgartner Martin; Nees Matthias
Publisher: Wiley
: 2024
: Cancer Medicine
: Cancer Medicine
: 13
: 18
: 2045-7634
: 2045-7634
DOI: https://doi.org/10.1002/cam4.70306
: https://doi.org/10.1002/cam4.70306
The cover image is based on the article Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models by Syeda Afshan et al., https://doi.org/10.1002/cam4.70240.
:
Turku University Foundation/Turun Yliopistosäätiö (080956, S.A.), the Finnish-Norwegian Medical Foundation/Suomalais-Norjalainen Lääketieteen Säätiö (2022043, S.A.), the Southwest Finland Cancer Organization/Lounaissuomalaiset Syöpäjärjestöt (S.A.), Ida Montinin Säätiö, Finland (20230339, S.A.), the Drug Research Doctoral Program of the University of Turku, Finland (S.A.), the Paulo Foundation/Paulon Säätiö, Finland (S.A.), the Swiss National Science Foundation (SNF_310030_188793, M.B.), the Swiss Cancer Research Foundation (KFS-4853-08-2019, M.B.), Academy of Finland (267326, 309372; M.N., P.H.), the European Union's TransPot Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement (721746, M.N., P.H., S.A.) and open access funding provided by University of Turku (UTU).
